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Abstract
Background: Posterior cortical atrophy is a clinical syndrome that is characterized by the progressive loss of visuospatial integration and is associated with
neurodegenerative conditions.
Case Report: We describe a 60-year-old female with simultanagnosia, oculomotor apraxia, and optic ataxia for which she received an initial clinical diagnosis of
posterior cortical atrophy. Three years later, she developed Balint’s syndrome, Gerstmann’s syndrome, left alien hand syndrome, smooth asymmetric (left) rigidity,
cortical sensory loss, and spontaneous myoclonic jerks of the left arm, which suggested a final diagnosis of corticobasal syndrome.
Discussion: This case report indicates that corticobasal syndrome may present with visuospatial deficits.
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Introduction
Posterior cortical atrophy (PCA) is a neurodegenerative syndrome
that is characterized by the progressive decline of multiple cognitive
functions, such as visuoperceptual and visuospatial skills, and arises
from the dysfunction of parieto-occipital regions.1 Age at onset is
typically between 50 and 65 years, and patients usually first present to
ophthalmologists with difficulties in fine vision tasks distinguishing lines
and reading texts, judging distances, identifying static objects within
the visual field, or problems with stairs and escalators.2 After
ophthalmologic consultation, and sometimes after receiving unneces-
sary medical procedures, such as cataract surgery, patients are
sometimes referred to psychiatrists for evaluations for depression,
anxiety, or malingering, which are frequently thought to be responsible
for the complaints.
The symptoms typically progress over a brief time span, and careful
neuropsychological evaluation often reveals signs of cognitive decline
that are not only related to visuospatial abilities but also include
ideational and ideomotor apraxia, dyscalculia, problems with spelling,
and memory deficits. Although physical examination does not
reveal signs of dysfunction in other systems of the central nervous
system, the occurrences of extrapyramidal signs, myoclonus, and
grasp reflex are reported in most cases of PCA; these symptoms
occur with prevalences similar to those observed in typical
Alzheimer’s disease (AD).3 The pathologic substrates of PCA include
AD (62%) in the majority of cases, dementia with Lewy bodies (10%),
corticobasal degeneration (CBD) (22%), prion disease, and subcortical
gliosis.1,2
Corticobasal syndrome (CBS) is a clinical phenotype that may be
associated with a variety of neurodegenerative diseases.4 CBS is
characterized by asymmetric presentation of two of the following
signs 1) limb rigidity or akinesia, 2) limb dystonia, and 3) limb
myoclonus, plus two of the following signs 4) orobuccal or limb
apraxia, 5) cortical sensory deficit, and 6) alien limb phenomena.4
Cases of CBS that also present with a complex visuospatial disorder,
such as Balint’s syndrome (simultanagnosia, optic ataxia, oculomotor
apraxia), that is present from early onset have also been reported.5,6 In
this report, we describe a case of PCA that developed to CBS over a
span of 3 years.
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Case report
A 60-year-old right-handed female presented to our outpatient
memory clinic for evaluation in late 2009. She claimed to have
developed difficulties in the performance of complex visual tasks such
as locating items or orienting herself in familiar surroundings. She
had contacted several ophthalmologists, but all consultants had
excluded ocular diseases. She finally sought neurological consultation
on advice from her general physician and on the general complaint
of depressive symptoms and memory deficits. The patient could not
finely locate items in her visual field and encountered great difficulties
in the performance of domestic work. Her physical examination
revealed intact extrinsic eye movements on voluntary command
(pursuit and saccades), normal intrinsic ocular motility, and the
absence of pyramidal, extrapyramidal, cerebellar, and sensory signs.
She was unable to move her view toward specific visual objects in her
peripheral field upon request (oculomotor apraxia) or to reach out
and touch objects with either arm by visual guidance (optic ataxia).
She could not recognize more than one item at a time (simultanagno-
sia) when tested with the Cookie Theft Picture from the Boston
Diagnostic Aphasia Examination.7 Extensive neuropsychological
examination revealed deficits on the Clock Drawing Test,8 Trail
Making Tests A and B,9 and the Stroop Test.10 Her corrected Mini
Mental State Examination (MMSEc)11 score was 26/30. Verbal
and autobiographic memories were normal at that time.12 Brain
magnetic resonance imaging (MRI) revealed posterior cortical atrophy,
enlargement of the posterior horns of the lateral ventricles, and
hyperintensities in the optical radiations. An assessment of brain
perfusion with 99mTc-ECD (Ethyl Cysteinate Diolef)-SPECT revealed
complete obscuration of the visual association areas within both occipital
regions (Figure 1A,B). A dopamine transporter (DaT) scan revealed a
normal representation of dopaminergic nerve terminals within the basal
ganglia. Ultimately, a diagnosis of PCA was made according to
established criteria,1,2 and the patient began treatment with rivastigmine
(4.6 mg/day). This treatment was subsequently slowly titrated up to
9.5 mg/day in the belief that she might have been affected by the
posterior variant of AD. The patient was included in a periodic program
of visits to our memory clinic, and she attended our outpatient
laboratory twice a year in the following years. Two years later, on her
first visit in 2011, she exhibited mild progressive worsening of her
cognitive deficits with short-term memory involvement. Neurological
Figure 1. Brain Scans and Imaging. In 2009, a perfusional 99mTc-ECD-SPECT brain scan of the patient revealed bilateral hypoperfusion of the visual association
cortices (arrows) (A). Brain magnetic resonance imaging revealed hyperintensities of the optical radiations and bilateral parieto-occipital atrophy (B). In 2012, 99mTc-
ECD-SPECT revealed an area of perfusional deficit within the post-central right lobule (arrow) (C). MRI revealed atrophy of the post-central parietal lobule (thick arrow)
and increased and asymmetric dilatation of the posterior horn of the right lateral ventricle (small arrow) (D).
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examination at that time revealed persistence of Balint’s syndrome and
the appearance of a Gerstmann’s syndrome (finger agnosia, acalculia,
dysgraphia, and right–left disorientation). In 2012, she slowly developed
a complex movement disorder that included left alien hand syndrome,
smooth asymmetric (left) rigidity, cortical sensory loss, and spontaneous
myoclonic jerks of the left arm. MRI at that time revealed increased
atrophy of the right post-central parietal lobule with enlargement of the
posterior horn of the right lateral ventricle, and an overwhelming
absence of perfusion of brain 99mTc-ECD-SPECT within that area
(Figure 1C,D). Extensive neuropsychological testing revealed severe
ideomotor apraxia and deficits in working memory, planning, naming,
and the abstract conceptualization of time. She also presented with a
deficit of immediate verbal recall and inattention. Her MMSEc score
was 14/30. CBS was the final diagnosis on the basis of recently
established diagnostic criteria.4 Video 1 illustrates the patient’s
syndrome.
Discussion
Several clinical syndromes can be caused by different underlying
neuropathologies. PCA and CBS share similar pathogenetic mechan-
isms, and the same neuropathologic conditions might underlie both
conditions, albeit in different proportions. PCA might be associated
with AD, CBD, or Lewy body disease (LBD).1,2,6,13,14 CBS can
originate from AD, CBD, frontotemporal lobar degeneration,
progressive supranuclear palsy, or Creutzfeldt–Jacob Disease.15
There are currently no methods to ascertain the underlying pathology
while the patient is alive, with the exception of the assessment of
amyloid burden with Pittsburg compound B (PiB) positron emission
tomography. Several distinctive clinical signs and symptoms have been
suggested to predict both of these histopathologies,16 and diagnostic
protocols may be supported by searches for biomarkers via analyses of
cerebrospinal fluid (CSF), MRIs, and the study of brain metabolism
with scintigraphic methods.
In CBS, episodic memory complaints and poor performance in
orientation memory testing seem to predict AD pathology, whereas
behavioral symptoms, such as non-fluent language disturbances,
apraxia, and utilization behavior, are associated with CBD pathol-
ogy.16 Mixed phenotypes are more difficult to categorize and may
either arise from mixed pathologies or represent unique evolutions of
neurodegenerative conditions. The features of different neurodegen-
erative diseases, such as AD and LBD, have been found to coexist in
the brains of both clinically probable AD and mild cognitive
impairment patients.17 One case of alien hand syndrome with
pathologically proven AD has been described.18 The patient reported
herein presented with pure Balint’s syndrome, which strongly
suggested the PCA variant form of AD. This hypothesis was further
strengthened by the appearance of memory defects a short time later.
Unfortunately, the pharmacologic response to rivastigmine was
lacking. Imaging analysis at that time revealed a dysfunction of the
visual association cortex that was consistent with the patient’s inability
to detect and reach objects in the peripheral visual field. The later
involvement of the post-central right lobule was more consistent with
CBS. Whether this complex syndrome arose from a variant form of
AD or from CBD is unclear. The early appearance of memory and
visuospatial deficits at presentation is suggestive of AD pathology.16 In
contrast, the presence of inattention and executive dysfunction in the
very early stages and the long-term sparing of the hippocampi are
suggestive of CBD pathology.16 The lack of data from CSF analyses
due to the patient’s refusal to submit to lumbar puncture did not allow
the collection of further information about the underlying pathology.
Moreover, the current diagnostic criteria for PCA and CBS did not
improve the accuracy of the diagnosis. These diagnostic criteria are
based on clinical signs and symptoms that are not informative about
the actual underlying degenerative condition,4,16 and show poor clinic-
pathological correlations.15 These issues are concerns for a number of
applications. First, these criteria do not allow for the prediction of the
clinical course of the neurodegenerative condition with any reliability,
and clinicians should be careful to avoid categorizing such rare
variants at presentation and incorrectly informing the relatives and the
Video 1. Posterior Cortical Atrophy: Corticobasal Syndrome at its
Final Presentation. The video demonstrates the patient’s left alien hand
phenomenon, oculomotor apraxia, right–left confusion, finger agnosia, and
ideomotor apraxia. Denomination and vision of single elements were intact. The
video shows the patient being asked to repeat ‘‘Oggi e` una bella giornata di sole
(Today is a beautiful sunny day)’’ to evaluate prosody and intonation; ‘‘Quante
dita vedi (How many fingers do you see?)’’ while the examiner was showing two
fingers of his right hand to evaluate elementary vision; ‘‘Che cosa e` un gatto?
(What category does a cat belong to?)’’ to evaluate semantic language;
‘‘Mostrami la tua mano destra (Show me you right hand)’’ to evaluate the
recognition of the right and left sides; ‘‘Per favore, conti usando le dita della
mano (Please, count using your fingers)’’ to assess finger agnosia; and ‘‘Per
favore, faccia il segno della croce (Please, make the sign of the cross)’’ to evaluate
ideomotor apraxia.
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patient about future outcomes. Second, the clinical diagnostic criteria
are not applicable to investigations that require direct consideration of
the underlying pathology such as clinical trials of disease-modifying
drugs. Third, these criteria do not allow for the proper and disease-
targeted management of symptoms. Fourth, these criteria do not
consider atypical forms of either AD or CBD, such as mixed or focal
presentations. Complex and mixed neurodegenerative diseases might
present with symptoms of each of the underlying conditions that
exhibit different burdens and speeds of progression. The empo-
werment of histopathology-targeted diagnostic protocols for neurode-
generative diseases is highly desirable and should be achieved
using disease-specific biomarkers. Until markers suitable for scinti-
graphic assessments of either taupathies or synucleinopathies are
developed, brain PET scans utilizing either 11C-PiB or 18F-labeled
radioligands should be performed whenever possible and used as AD
diagnostic tools for all patients who are affected by rare, bridging
variants of complex conditions that couple dementia and movement
disorders. The diagnostic algorithm should include a complete blood
examination and metabolic or perfusional brain scintigraphy. CSF
analysis for b-amyloid fragments and tau, phospho-tau and 14-3-3
proteins can be performed, but only after acquiring informed consent.
This study demonstrates that the rare and complex clinical syndromes
that arise from variants of common diseases or from mixed
neurodegenerative disorders might have distinct and unpredictable
clinical courses.
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